drugset / Trial / NCT06555575

Ubiquinone vs. Ubiquinol Supplementation

NCT06555575

Phase 2 Recruiting 90 enrolled Trio Fertility
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to determine if ubiquinol will result in improved reproductive outcomes in older women at a reduced oral dose compared to current standard treatment with ubiquinone.

Timeline

Start
2025-01-23
Primary completion
2026-09-01
Completion
2027-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Coenzyme Q10 Other / unclassified 200 mg Oral
Subject Ubiquinol Unknown 100 mg Oral

Indications

No indication recorded.